In chronic lymphocytic leukemia (CLL), low TLR2 expression is linked to a poor prognosis, while in mantle cell lymphoma (MCL), TLR4 signaling can trigger tumor growth. Here, TLR2 is linked to B-cell chronic lymphocytic leukemia.